Evidence map›Paper›PMID 41330120›Full record

ReviewInternational dental journal2026

Harnessing and Optimizing α-TCP for Oral Tissue Engineering and Regenerative Dentistry.

Wenbo Du, Yadong Guo, Janak Lal Pathak, Chen Xiaoshi, Hanfu Su, Liping Wang

Abstract readReview
In one paragraph

Review in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenbo DuDepartment of Implantology, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China.
Yadong GuoDepartment of Implantology, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China.
Janak Lal PathakDepartment of Implantology, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China.
Chen XiaoshiDepartment of Implantology, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China.
Hanfu SuDepartment of Implantology, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China. Electronic address: hanfusu@gzhmu.edu.cn.
Liping WangDepartment of Implantology, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, China. Electronic address: wangliplj@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-Tricalcium phosphate (α-TCP), a resorbable calcium phosphate bioceramic, has emerged as a promising biomaterial for oral tissue regeneration due to its exceptional osteoconductive properties and compositional similarity to natural bone. During hydrolysis, α-TCP releases calcium (Ca²⁺) and phosphate (PO₄³⁻) ions that actively promote tissue mineralization, making it particularly valuable for applications in periodontal bone repair, periapical lesion treatment, and dental hard tissue remineralization. However, while α-TCP demonstrates excellent initial osteogenic activity, its rapid degradation kinetics in physiological environments often lead to premature structural collapse, localized hyperphosphatemia, and inconsistent bone formation outcomes. This review examines the current applications of α-TCP in oral medicine, with particular focus on its clinical use in apexification, alveolar ridge preservation, and guided bone regeneration. We critically analyse the material's limitations, including its mechanical instability in load-bearing sites and unpredictable resorption profiles that may hinder long-term regenerative outcomes. Emerging strategies to overcome these challenges are discussed, such as the development of composite systems combining α-TCP with β-TCP, hydroxyapatite, or biodegradable polymers to achieve optimized degradation rates and enhanced mechanical performance. Furthermore, we explore innovative approaches in material design, including surface functionalization with bioactive molecules and the fabrication of three-dimensional printed (3D-printed) α-TCP scaffolds with controlled porosity. The review concludes by identifying key research directions for the field, emphasizing the need for improved in vivo degradation models, standardized clinical evaluation protocols, and the development of smart α-TCP composites capable of spatiotemporal control over ion release. By addressing these challenges, α-TCP-based materials may realize their full potential as next-generation solutions for oral tissue engineering and regenerative dentistry. Furthermore, this review uniquely synthesizes the literature by grouping findings according to key performance outcomes - including mechanical strength, degradation kinetics, and osteogenic efficacy - to provide a clear, comparative analysis of how different material design strategies directly influence biological and functional results.

Indexed as

Biocompatible MaterialsCalcium PhosphatesTissue EngineeringBone RegenerationHumansRegenerative Medicinealpha-tricalcium phosphateBiocompatible MaterialsCalcium PhosphatesBone substitutesDental biomaterialsOral tissue regenerationα-Tricalcium phosphate

Identifiers

PMID41330120
PMCPMC12718465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.